Literature DB >> 16866696

High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans.

Diego Geroldi, Colomba Falcone, Piercarlo Minoretti, Enzo Emanuele, Mariarosa Arra, Angela D'Angelo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16866696     DOI： 10.1111/j.1532-5415.2006.00776.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  19 in total

Review 1.  The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

2.  Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.

Authors:  Weijing Cai; John Cijiang He; Li Zhu; Xue Chen; Sylvan Wallenstein; Gary E Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

3.  Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment.

Authors:  R Ghidoni; L Benussi; M Glionna; M Franzoni; D Geroldi; E Emanuele; G Binetti
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

4.  Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).

Authors:  Barry I Hudson; Yeseon Park Moon; Anastasia Z Kalea; Minesh Khatri; Chensy Marquez; Ann Marie Schmidt; Myunghee C Paik; Mitsuhiro Yoshita; Ralph L Sacco; Charles DeCarli; Clinton B Wright; Mitchell S V Elkind
Journal:  Atherosclerosis       Date:  2011-01-21       Impact factor: 5.162

5.  A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging.

Authors:  Fabian Sanchis-Gomar; Helios Pareja-Galeano; Alejandro Santos-Lozano; Nuria Garatachea; Carmen Fiuza-Luces; Letizia Venturini; Giovanni Ricevuti; Alejandro Lucia; Enzo Emanuele
Journal:  Age (Dordr)       Date:  2015-04-25

Review 6.  Clinical utility of novel biomarkers for cardiovascular disease risk stratification.

Authors:  Maurizio Averna; Davide Noto
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 7.  RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review.

Authors:  Gowri Palanissami; Solomon F D Paul
Journal:  Horm Cancer       Date:  2018-07-09       Impact factor: 3.869

Review 8.  The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies.

Authors:  Andisheh Abedini; Julia Derk; Ann Marie Schmidt
Journal:  Protein Sci       Date:  2018-07       Impact factor: 6.725

9.  Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases.

Authors:  Lih-Fen Lue; Douglas Gordon Walker; Sandra Jacobson; Marwan Sabbagh
Journal:  Future Neurol       Date:  2009

Review 10.  Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Biochem Pharmacol       Date:  2010-01-22       Impact factor: 5.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.